Latest Partnerships News

Thunderbird Resources reports standout gold and antimony assay results from NSW projects, while reshaping its copper and uranium joint ventures in Peru and Canada.

Noronex Limited reports promising new copper mineralisation from diamond drilling at its Fiesta Project and extends its strategic alliance with South32 into Botswana, alongside appointing a new CEO to spearhead growth.

Icon Energy Limited reported a stable cash position of $431,414 at the end of June 2025, with no exploration activity during the quarter as it awaits final approval of Petroleum Lease PL-1144. The company plans to pursue joint venture partnerships once the lease is granted.

Biotron Limited has successfully raised $1.27 million through an entitlement issue to fund its antiviral drug development, including a promising Hepatitis B compound that cleared its initial animal safety study.

Mount Burgess Mining advances metallurgical test work at its Nxuu deposit, navigates leadership changes, and pursues a significant legacy debt extinguishment as it refines its strategic focus.

Aurora Energy Metals has secured a six-month extension on Eagle Energy Metals' exclusive option for its flagship uranium project, accompanied by significant cash inflows and advancing metallurgical work. The company ends the quarter debt-free with a solid cash buffer as it pushes forward on multiple fronts.

Zoono Group Limited reports strong progress in its shelf-life extension technology with 45 active trials worldwide and anticipates UK revenue by Q2 FY26 following successful supermarket partnerships.

EQ Resources has locked in a US$7.5 million royalty funding agreement with Oaktree Management, aimed at expanding and enhancing its Barruecopardo tungsten project in Spain. This deal strengthens the company’s balance sheet and supports critical capital projects to increase production capacity.

Beonic has landed a landmark AU$15.2 million contract to deploy its LiDAR passenger flow technology across seven major North African airports, marking a strategic expansion into the region ahead of a major 2030 sporting event.

Radiopharm Theranostics reports significant progress in its oncology radiopharmaceutical pipeline, including FDA Fast Track designation and dose escalation approvals, supported by a solid cash runway through mid-2026.

Resolution Minerals Limited is set to pursue a dual-listing on the NASDAQ in Q4 2025, aiming to tap into deeper U.S. capital markets and enhance its profile among American investors. The move supports the development of its critical minerals Horse Heaven project in Idaho, aligning with U.S. national security interests.

Diatreme Resources has formalised a negotiation framework with the Gulaal People, setting the stage for collaborative development of its Northern Silica Project while prioritising cultural heritage and community benefits.